Τετάρτη 10 Μαΐου 2017

Trial aims to extend remission for children treated with T-cell immunotherapy for leukaemia

After phase 1 results of Seattle Children's Paediatric Leukaemia Adoptive Therapy (PLAT-02) trial have shown T-cell immunotherapy to be effective in getting 93 percent of patients with relapsed or refractory acute lymphoblastic leukaemia (ALL) into...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pwpFAY
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις